Deutsche Bank
RUBY

Deutsche Bank’s Rubius Therapeutics, Inc RUBY Stock Holding History

Deutsche Bank’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-150,000
Closed -$26.3K – 4046
2022
Q4 		$26.3K Hold
150,000
– – ﹤0.01% 3727
2022
Q3 		$65K Hold
150,000
– – ﹤0.01% 3515
2022
Q2 		$128K Buy
150,000
+123,234
+460% +$207K ﹤0.01% 3396
2022
Q1 		$147K Sell
26,766
-23,748
-47% -$151K ﹤0.01% 3422
2021
Q4 		$489K Sell
50,514
-1,028
-2% -$14.3K ﹤0.01% 2868
2021
Q3 		$921K Buy
51,542
+2,152
+4% +$46.8K ﹤0.01% 2675
2021
Q2 		$1.21M Buy
49,390
+5,030
+11% +$126K ﹤0.01% 2654
2021
Q1 		$1.18M Sell
44,360
-3,242
-7% -$47.4K ﹤0.01% 2565
2020
Q4 		$361K Buy
47,602
+6,380
+15% +$37.9K ﹤0.01% 3128
2020
Q3 		$206K Buy
41,222
+22,546
+121% +$119K ﹤0.01% 3197
2020
Q2 		$112K Buy
18,676
+6,057
+48% +$35.8K ﹤0.01% 3387
2020
Q1 		$56K Sell
12,619
-13,298
-51% -$98.8K ﹤0.01% 3492
2019
Q4 		$245K Buy
25,917
+8,573
+49% +$82.9K ﹤0.01% 3097
2019
Q3 		$135K Sell
17,344
-6,163
-26% -$71.8K ﹤0.01% 3399
2019
Q2 		$367K Sell
23,507
-14,707
-38% -$237K ﹤0.01% 3479
2019
Q1 		$689K Buy
38,214
+29,840
+356% +$458K ﹤0.01% 3241
2018
Q4 		$133K Sell
8,374
-19,190
-70% -$350K ﹤0.01% 4085
2018
Q3 		$662K Buy
+27,564
New +$630K ﹤0.01% 3597

Other funds holding RUBY

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Deutsche Bank's RUBY Position: Q1 2023 in Review

Deutsche Bank sold out of Rubius Therapeutics, Inc (RUBY) in Q1 2023, closing a stake of 150,000 shares — an estimated $26.3K sold.

Deutsche Bank first reported a position in RUBY in Q3 2018 and held it in 18 quarters. The position peaked at $1.21M in Q2 2021. 7 funds tracked by Wall St. Rank hold RUBY as of Q1 2023.

  • Deutsche Bank reported no remaining Rubius Therapeutics, Inc position as of Q1 2023 after selling out during the quarter.
  • Deutsche Bank sold 150,000 Rubius Therapeutics, Inc shares in Q1 2023, an estimated $26.3K.
  • Deutsche Bank first reported a position in Rubius Therapeutics, Inc in Q3 2018 and held it in 18 quarters.
  • Deutsche Bank's Rubius Therapeutics, Inc position peaked at $1.21M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q1 2023.

Based on Deutsche Bank's 13F filing for Q1 2023, filed 15 May 2023.